AksharChem (India) Limited Schedules Board Meeting on May 21, 2026 to Consider Q4FY26 Audited Results and Final Dividend

1 min read     Updated on 13 May 2026, 09:11 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

AksharChem (India) Limited has informed stock exchanges of a Board of Directors meeting on May 21, 2026, to consider audited financial results for the quarter and financial year ended March 31, 2026, and to recommend a final dividend on equity shares for FY2025-26, if any. The Trading Window for designated persons has been closed since April 01, 2026, and will reopen 48 hours after the declaration of results, per SEBI (Prohibition of Insider Trading) Regulations, 2015.

powered bylight_fuzz_icon
40231906

*this image is generated using AI for illustrative purposes only.

AksharChem (India) Limited has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Thursday, May 21, 2026, in compliance with Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will deliberate on the audited financial results for the quarter and financial year ended March 31, 2026, and consider a recommendation on the final dividend on equity shares for FY2025-26, if any.

Board Meeting Details

The key agenda items for the upcoming board meeting are outlined below:

Parameter: Details
Meeting Date: Thursday, May 21, 2026
Purpose: Audited Financial Results for Q4 and Full Year FY2025-26
Period Under Review: Quarter and Financial Year ended March 31, 2026
Dividend Consideration: Final dividend on equity shares for FY2025-26, if any
Regulatory Reference: Regulation 29(1) of SEBI (LODR) Regulations, 2015

Trading Window Closure

In continuation of its earlier communication dated March 26, 2026, AksharChem has confirmed that the Trading Window for dealing in securities of the company by its designated persons and their immediate relatives has been closed since April 01, 2026. The Trading Window will be reopened 48 hours after the declaration of the financial results to the stock exchanges, in accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal code for prevention of insider trading.

The intimation was signed by Mehul Naliyadhara, Company Secretary & Compliance Officer of AksharChem (India) Limited, on May 13, 2026. The company is headquartered at Arista 8, Behind Rajpath Club, Bodakdev, Ahmedabad, Gujarat - 380059.

Historical Stock Returns for AksharChem

1 Day5 Days1 Month6 Months1 Year5 Years
-0.87%-6.70%+8.76%-24.64%-16.63%-30.42%

How does AksharChem's expected FY2025-26 dividend payout compare to its historical dividend yield, and what does this signal about the company's cash flow position?

Given the trading window closure since April 1, 2026, have there been any notable changes in institutional or promoter shareholding patterns that could hint at market sentiment ahead of the results?

How might AksharChem's Q4 and full-year FY2025-26 financial performance reflect broader trends in India's specialty chemicals and dyes sector amid global demand shifts?

Aksharchem (India) Limited Confirms Non-Large Corporate Status in SEBI Regulatory Disclosure

1 min read     Updated on 10 Apr 2026, 08:06 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Aksharchem (India) Limited filed regulatory disclosure confirming non-Large Corporate status under SEBI framework. The company reported outstanding borrowings of ₹27.96 crores as of March 31, 2026, with CARE A-; Stable ratings for long-term facilities and CARE A2+ for short-term facilities from CARE Ratings Limited.

powered bylight_fuzz_icon
37334172

*this image is generated using AI for illustrative purposes only.

Aksharchem (India) Limited has submitted its mandatory regulatory disclosure to BSE Limited and National Stock Exchange of India, confirming that the company does not qualify as a Large Corporate under the SEBI framework established through circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018.

Regulatory Compliance Disclosure

The company filed its initial disclosure on April 9, 2026, through Company Secretary and Compliance Officer Mehul Naliyadhara. This submission is required under SEBI regulations concerning fund raising by issuance of debt securities by large corporates.

Financial Position and Credit Profile

The disclosure reveals key financial metrics and credit standing of the company as of March 31, 2026:

Parameter: Details
Outstanding Borrowing: ₹27.96 crores
Long Term/Short Term Bank Facilities: CARE A-; Stable/ CARE A2+
Short Term Bank Facilities: CARE A2+
Long Term Bank Facilities: CARE A-; Stable
Credit Rating Agency: CARE Ratings Limited

SEBI Framework Implications

Under the SEBI circular, entities classified as Large Corporates are subject to specific requirements for borrowing through debt securities. The framework includes mandatory borrowing thresholds and potential penalties for non-compliance.

Aksharchem (India) Limited has designated BSE Limited as the stock exchange where any applicable fine would be paid in case of shortfall in required borrowing under the framework, though this is not expected given their non-Large Corporate status.

Company Background

Aksharchem (India) Limited, incorporated with CIN L24110GJ1989PLC012441, operates from its registered office at Arista 8, Behind Rajpath Club, Bodakdev, Ahmedabad, Gujarat. The company maintains ISO certifications as evidenced by ISOQAR and UKAS Management Systems accreditations.

The disclosure was duly signed by both Company Secretary Mehul Naliyadhara and Chief Financial Officer Amit Soni, ensuring proper authorization and compliance with regulatory requirements.

Historical Stock Returns for AksharChem

1 Day5 Days1 Month6 Months1 Year5 Years
-0.87%-6.70%+8.76%-24.64%-16.63%-30.42%

What growth trajectory would Aksharchem need to achieve to potentially qualify as a Large Corporate under SEBI's framework in future years?

How might Aksharchem's current credit rating of CARE A- impact its ability to secure additional funding for expansion plans?

Will the company's non-Large Corporate status provide it with more flexible debt financing options compared to larger competitors?

More News on AksharChem

1 Year Returns:-16.63%